Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Ballets
3
Extractos
2
Música para violín y piano
2
Suites (Orquesta)
2
Army
1
Ballets (Música)
1
Canciones (voz con piano)
1
Church
1
Clergy
1
Excerpts
1
Iglesia
1
Militares
1
Música
1
Música bailable
1
Música de Cámara
1
Música orquestal
1
Música para Violín
1
Música para Violín y Piano
1
Música para Violín y Piano, Arreglos
1
Música para piano
1
Oberturas
1
Olimpiadas
1
Operas
1
Pintura moderna
1
Polka (Danza)
1
Sinfonías
1
Suites (Orchestra)
1
Veracruz
1
Veracruz/Soldiers
1
clero
1
-
381por Tumyan, Gayane, Hamidi, Oksana, Christie, Alana, Mifrakhraee, Sasan, Dohopolski, Michael, Gottumukkala, Sujana, Hannan, Raquibul“…In patients with adrenal metastases requiring local treatment, stereotactic ablative radiation therapy (SAbR) has been shown to be well tolerated. Yet, data on the development of AI following adrenal SAbR are scarce. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
382por van Dorp, Martijn, Trimbos, Constantia, Schreurs, Wilhelmina H., Dickhoff, Chris, Heineman, David J., Torensma, Bart, Kazemier, Geert, van den Broek, Frank J. C., Slotman, Ben J., Dahele, Max“…Median follow-up was 38 months (IQR: 26–67) in the surgery group and 46 months (IQR: 30–79) in the SABR group. Median OS was 58 months (CI: 20–94) in the metastasectomy group and 70 months (CI: 29–111) in the SABR group (p = 0.23). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
383“…SIMPLE SUMMARY: Stereotactic ablative radiation therapy (SAbR) is a safe and effective local therapy for renal cell cancer (RCC) with emerging and evolving indications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
384por Mehrens, Dirk, Unterrainer, Marcus, Corradini, Stefanie, Niyazi, Maximilian, Manapov, Farkhad, Westphalen, C. Benedikt, Froelich, Matthias F., Wildgruber, Moritz, Seidensticker, Max, Ricke, Jens, Rübenthaler, Johannes, Kunz, Wolfgang G.“…BACKGROUND: In certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative radiation (SABR) compared to patients receiving standard care (SC) alone. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
385por Yang, Jen-Fu, Lo, Cheng-Hsiang, Lee, Meei-Shyuan, Lin, Chun-Shu, Dai, Yang-Hong, Shen, Po-Chien, Chao, Hsing-Lung, Huang, Wen-Yen“…We suggest that SABR should be the preferred technique for HCC patients with PVI.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
386por Schoenhals, Jonathan E., Mohamad, Osama, Christie, Alana, Zhang, Yuanyuan, Li, Daniel, Singla, Nirmish, Bowman, Isaac, Arafat, Waddah, Hammers, Hans, Courtney, Kevin, Cole, Suzanne, Bagrodia, Aditya, Margulis, Vitaly, Desai, Neil, Garant, Aurelie, Choy, Hak, Timmerman, Robert, Brugarolas, James, Hannan, Raquibul“…We evaluated the effect of stereotactic ablative radiation therapy (SAbR) for longitudinal control of oligoprogressive mRCC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
387por Liu, Chao, Hu, Qinyong, Hu, Kai, Su, Huichao, Shi, Fang, Kong, Li, Zhu, Hui, Yu, Jinming“…However, the predictors of immune cells for tumor response after SABR are unknown. To that effect, we investigated the ability of pre-SABR immune cells in peripheral blood to predict early tumor response to SABR in patients with lung metastases from NSCLC. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
388por Morias, Stamati, Marcu, Loredana G., Short, Michala, Giles, Eileen, Potter, Andrew, Shepherd, Justin, Gierlach, Thanh, Bezak, Eva“…While many studies assess safety, clinical efficacy, and disease control of SABR for lung cancer, the number of comprehensive reviews that analyse SABR-related side-effects is scarce. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
389por Phillips, Ryan, Shi, William Yue, Deek, Matthew, Radwan, Noura, Lim, Su Jin, Antonarakis, Emmanuel S., Rowe, Steven P., Ross, Ashley E., Gorin, Michael A., Deville, Curtiland, Greco, Stephen C., Wang, Hailun, Denmeade, Samuel R., Paller, Channing J., Dipasquale, Shirl, DeWeese, Theodore L., Song, Daniel Y., Wang, Hao, Carducci, Michael A., Pienta, Kenneth J., Pomper, Martin G., Dicker, Adam P., Eisenberger, Mario A., Alizadeh, Ash A., Diehn, Maximilian, Tran, Phuoc T.“…SABR induced a systemic immune response, and baseline immune phenotype and tumor mutation status may predict the benefit from SABR. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
390“…Stereotactic ablative body radiotherapy (SABR) has a role as definitive therapy in many tumor sites; however, its role in the treatment of breast cancer is less well explored. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
391“…Logistic regression and Cox regression identified predictors of stereotactic ablative body radiotherapy (SABR) and survival, respectively. RESULTS: We identified 754 patients, with 238 (32%) treated with SABR. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
392“…SABR appears to be feasible to deliver, well tolerated and may delay the next line of therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
393por Pellizzon, Antonio, Silva, Maria, Fogaroli, Ricardo, Neto, Elson, Chen, Michael, Godim, Guilherme, Castro, Douglas, Ramos, Henderson, Abrahao, Carolina“…The median time between salvage surgery and PO-SABR was 31 days (range, 25–42) and the median PO-SABR total dose was 40 Gy (range, 30–48 Gy). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
394por Bai, Yun, Gao, Xian-shu, Qin, Shang-bin, Chen, Jia-yan, Su, Meng-meng, Liu, Qing, Qin, Xiu-bo, Ma, Ming-wei, Zhao, Bo, Gu, Xiao-bin, Xie, Mu, Cui, Ming, Qi, Xin, Li, Xiao-ying“…The P-SABR plan consisted of one partial SABR plan (5–9 Gy/f, 3–6 fractions) to gross tumor boost (GTVb), followed by one CRT plan to the planning target volume (PTV). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
395por Voong, Khinh Ranh, Illei, Peter B, Presson, Bradley, Singh, Dipika, Zeng, Zhen, Lanis, Mara, Hales, Russell K, Hu, Chen, Tran, Phuoc T, Georgiades, Christos, Lin, Cheng Ting, Thiboutout, Jeffrey, Brahmer, Julie R, Forde, Patrick M, Naidoo, Jarushka, Anagnostou, Valsamo, Smith, Kellie N“…Here, we evaluate the early pathologic and immunologic effects of SABR. Blood/core-needle tumor biopsies were collected from six patients with stage I NSCLC before and 5–7 days after SABR (48 Gy/4 or 50 Gy/5 fractions). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
396por Tu, Chih-Yen, Hsia, Te-Chun, Fang, Hsin-Yuan, Liang, Ji-An, Yang, Su-Tso, Li, Chia-Chin, Chien, Chun-Ru“…The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
397por Lee, Yoo Young Dominique, Nguyen, Doan Trang, Moodie, Trevor, O’Brien, Ricky, McMaster, Anne, Hickey, Andrew, Pritchard, Nicole, Poulsen, Per, Tabaksblat, Elizaveta Mitkina, Weber, Britta, Worm, Esben, Pryor, David, Chu, Julie, Hardcastle, Nicholas, Booth, Jeremy, Gebski, Val, Wang, Tim, Keall, Paul“…BACKGROUND: Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
398por Ali, Muhammad, Wood, Simon, Pryor, David, Moon, Daniel, Bressel, Mathias, Azad, Arun A., Mitchell, Catherine, Murphy, Declan, Zargar, Homi, Hardcastle, Nick, Kearsley, Jamie, Eapen, Renu, Wong, Lih Ming, Cuff, Katharine, Lawrentschuk, Nathan, Neeson, Paul J., Siva, Shankar“…Patients will be randomised to either SABR or SABR/pembrolizumab. Patients in both arms will undergo surgery at 9 weeks after completion of experimental treatment. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
399por Lucien, Fabrice, Kim, Yohan, Qian, Jing, Orme, Jacob J., Zhang, Henan, Arafa, Ali, Abraha, Feven, Thapa, Ishwor, Tryggestad, Erik J., Harmsen, William S., Kosti, Jorgena, Ali, Hesham, Lowe, Val J., Johnson, Geoff B., Kwon, Eugene D., Dong, Haidong, Park, Sean S.“…PURPOSE: SABR has demonstrated clinical benefit in oligometastatic prostate cancer. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
400por Li, Ming, Yang, Xiaodong, Chen, Yuhan, Yang, Xinyu, Dai, Xiyu, Sun, Fenghao, Zhang, Li, Zhan, Cheng, Feng, Mingxiang, Wang, Qun“…However, it has not been clarified whether SBRT/SABR is as effective as surgery. We conducted this study to compare the efficacy of SBRT/SABR and surgery in the treatment of T1-3N0M0 NSCLC. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto